1 / 19

MeTA Pilot Phase – Updates from the MeTA International Secretariat

MeTA Pilot Phase – Updates from the MeTA International Secretariat. 3 rd MeTA Philippines Forum, 26 th January 2010. What is MeTA?. A global alliance between DFID, World Bank, WHO, private sector, civil society, professional organisations.

indra
Download Presentation

MeTA Pilot Phase – Updates from the MeTA International Secretariat

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MeTA Pilot Phase – Updates from the MeTA International Secretariat 3rd MeTA Philippines Forum, 26th January 2010 MeTA

  2. What is MeTA? MeTA • A global alliance between • DFID, World Bank, WHO, private sector, civil society, professional organisations. • 7 pilot countries seeking improved access to medicines with: • Government, civil society and private Sector • An International Secretariat to support country work, and, upon request, technical assistance.

  3. What does MeTA want to achieve? MeTA MeTA goal: to increase access to essential medicines, especially for the poor in developing countries Concept of essential medicines is valid for all countries… But, after 30 years, 2 billion people are still not having access…

  4. Hypothesis for the pilot phase MeTA A multi-stakeholder collaboration of civil society, government and private sector will lead to more disclosure and accountability, and eventually improve access to medicines.

  5. How does MeTA try to do this? MeTA Multi-stakeholder collaboration Country led, bottom-up approach Requesting transparency and disclosure from all players Develop better information & greater accountability in the supply chain

  6. What should this lead to? MeTA All stakeholders better informed More trust and collaboration between stakeholders Analyzing the problems together Seeking improved, joint solutions Better policies Improved access to medicines...

  7. MeTA Country commitments MeTA • Establish an effective multi-stakeholder forum with public, private and civil society engagement • Progressive disclosure of data in four areas Quality Regulatory, sourcing, quality assurance, vigilance AvailabilitySupply chain operations, equitable access PriceSupplier, wholesaler, retailer, taxes, duties, affordability PromotionObjective information, rational use, ethical advertising

  8. Surveys, disclosure, analysis MeTA MeTA pilot countries have started publishing household surveys and disclosed data Time for MeTA councils and multi-stakeholder groups to analyse the data Try to make joint conclusions And seek joint solutions

  9. Where are we in the MeTA pilot timeline? MeTA 2007 – preparing for MeTA Dec 2007 – 1st Forum Philippines May 2008 – Global launch of MeTA 2009 – implementing MeTA ← ← 2010 – External evaluation ← ← 17-22 May 2010 – WHO Assembly 28 June – 2 July 2010 - Global meeting 30 Sept 2010 – end phase 1; start MeTA-2…

  10. MeTA evaluation MeTA An independent external evaluation of the MeTA pilot phase has started. The results will assist the UK government to decide whether it will honour its original commitment to MeTA for the coming 8 years Report should be available April/May

  11. Key in-country Successes (I)

  12. Key in-country Successes (II)

  13. Main Challenges (I)

  14. Main Challenges (II)

  15. Synthesis of Lessons Learned (I) • National Councils and Secretariats • Necessary to build capacity for Council & Secretariat members in communication and facilitation • Establishing Technical Committees to work on specific areas is helpful but membership should be chosen carefully to ensure efficiency and productive outcomes • Maintaining engagement of Council members is difficult due to conflicting agendas • Workplan Implementation • Need to develop strategies to translate findings into actions • Political support is relevant and critical for success of MeTA: MeTA cannot operate in a political vacuum

  16. Synthesis of the Lessons Learned (II) • Multi-stakeholder process • Multi-stakeholder involvement helps to break barriers BUT it is necessary to build capacity of all stakeholders (including Private Sector) in pharmaceutical policy reform, communication skills and consensus building • Establishing consensus requires constant lobbying for exchange of views which can delay implementation of activities • MeTA CSO capacity building is necessary. CSO coalitions should include members that are able to engage in high level discussions. • Data collection, Disclosure and Dissemination • Transparency and accountability in the engagement of the process is vital for the success of MeTA • All stakeholders involved in MeTA should be willing to disclose information • Clearly defining ‘disclosure’ and ‘transparency’ is an essential exercise for the MeTA Council

  17. Complexity of change new and different voices innovation dynamic dialogues changing business practice transformation equity mutual accountability problem solving social justice different perspectives transparency new partnerships

  18. MeTA Philippines is invited to present… MeTA Here at the 3rd Forum… At the World Health Assembly in Geneva, 17-20 May 2010 At a MeTA global feedback meeting in London 28 June - 2 July 2010

  19. Congratulations! MeTA The International MeTA Secretariat is proud of MeTA Philippines’ achievements… And wishes MeTA Philippines a successful 3rd annual forum! Wilbert Bannenberg wbannenberg@metasecretariat.org www.MedicinesTransparency.org

More Related